Home Your basket
• Speech disorders, verbal ...
   Price 10.50 €
• ...
   Price 5.50 €
• Delayed facial palsy afte...
   Price 8.50 €
• Percutaneous gastrostomy ...
   Price 10.50 €
• Metastatic angiosarcoma t...
   Price 5.50 €
• A protocol for post-opera...
   Price 5.50 €
• Reconstruction after hemi...
   Price 14.00 €
• A survey of current wound...
   Price 5.50 €
• Traditional and emerging ...
   Price 10.50 €
• Hearing aids rehabilitati...
   Price 12.50 €
• Laryngeal tracheal post-i...
   Price 8.50 €
• Nasal cutaneous cryptococ...
   Price 5.50 €
• Acinic cell carcinoma in ...
   Price 8.50 €
• Perilymphatic Gusher as a...
   Price 10.50 €
• Laryngeal schwannoma: A c...
   Price 8.50 €
• «Mini-rhinoplasty»...
   Price 10.50 €
• Type III ossiculoplasty w...
   Price 5.50 €
• Malignant mixed tumor of ...
   Price 5.50 €
• Spontaneous subcutaneous ...
   Price 5.50 €
• Plastic surgery indicatio...
   Price 10.50 €
• Endoscopic sphenoid proce...
   Price 8.50 €
• Bilateral cochlear implan...
   Price 5.50 €
• A post-styloid mass revea...
   Price 12.50 €
• Hearing aid : practical a...
   Price 8.50 €
• Correlation between the r...
   Price 12.50 €
• TRT: Results after one ye...
   Price 10.50 €
• Retropharyngeal abscess i...
   Price 10.50 €
• Acoustic neuroma surgery....
   Price 10.50 €
• Therapeutic management of...
   Price 10.50 €
• Dysphagia, a geriatric po...
   Price 8.50 €
• Diagnostic value of vibra...
   Price 8.50 €
• Prospective study on 43 s...
   Price 10.50 €
• Sinonasal hemangiopericyt...
   Price 10.50 €
• Auditory screening in neo...
   Price 8.50 €
• Unilateral endolymphatic ...
   Price 10.50 €
• Universal hearing screeni...
   Price 10.50 €

Total Order 324.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 1 - 2010 o

PHONIATRICS

Voice related quality of life after botulinum toxin injection for spasmodic dysphonia


Authors : Gama A. C. C. 1<br />Menezes LN, Maia AA, Rezende Neto AL, Oliveira JB. (Belo Horizonte)

Ref. : Rev Laryngol Otol Rhinol. 2010;131,1:39-44.

Article published in english
Downloadable PDF document english



Summary : Introduction: Laryngeal Focal Dystonia (LFD) leads to a type of voice with a strained and tense quality which has a neurological origin, affecting the social-emotional realms of the individuals, and their quality of life. Aims: Measure the voice-related quality of life of patients with Adductor LFD pre and post-treatment with Botox®‚ injection followed by voice therapy, using the Voice-Related Quality of Life (V-RQOL). Study Design: Prospective study. Methods: Adductor 11 female patients aged between 33 and 74 years with a diagnosis of Adductor LFD were evaluated. All patients underwent a neurological evaluation. Laryngoscopy was performed with both rigid and flexible endoscopes. Speech and Language evaluation followed the Evaluation of Voice Protocol, proposed by Behlau, Pontes (1995). The American V-RQOL measure was utilized. Results: Statistical analysis demonstrated significant difference (p< 0,05). 81.8% of patients showed higher scores post-Botox®‚ for the social-emotional and physical domain. In the overall V-RQOL scores 72.7% of patients showed greater scores post-treatment. Conclusions: There was an improvement in the quality of life for these patients post-treatment. The V-RQOL proved to be an efficient tool to measure the treatment outcomes of LFD pre and post botulinum toxin injection.

Price : 10.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE